Free Trial

4D pharma (LBPSW) Competitors

LBPSW vs. ATNFW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGW

Should you be buying 4D pharma stock or one of its competitors? The main competitors of 4D pharma include 180 Life Sciences (ATNFW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry.

4D pharma vs.

180 Life Sciences (NASDAQ:ATNFW) and 4D pharma (NASDAQ:LBPSW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
4D pharma$522KN/AN/AN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled 4D pharma'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
4D pharma Neutral

180 Life Sciences and 4D pharma both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
4D pharmaN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
4D pharma N/A N/A N/A

Summary

4D pharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPSW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LBPSW vs. The Competition

Metric4D pharmaPharmaceutical Preparation Manufacturing IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$2.00B$7.63B
Dividend YieldN/AN/A2.75%4.33%
P/E RatioN/AN/A22.1418.17
Price / SalesN/AN/A55.72105.10
Price / CashN/AN/A51.7234.62
Price / BookN/AN/A1.964.19
Net IncomeN/AN/A-$333.48M$247.59M

4D pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-22.2%$0.00N/A0.007
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+9.1%
N/A-74.2%$0.00N/A0.002Gap Down
High Trading Volume
AIMDW
Ainos
N/A$0.11
+24.0%
N/A+37.8%$0.00$20,729.000.0040Gap Up
ALVOW
Alvotech
N/A$1.40
+26.1%
N/A-58.8%$0.00$489.68M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.05
-29.5%
N/A-8.2%$0.00$37.32M0.0070
BTMDW
biote
N/A$0.01
-2.3%
N/A-93.2%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.14
+7.8%
N/A-84.7%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.04
-3.3%
N/A+9.4%$0.00$48.20M0.00220Gap Down
CINGW
Cingulate
N/A$0.04
-17.8%
N/A+146.7%$0.00N/A0.0020Gap Down

Related Companies and Tools


This page (NASDAQ:LBPSW) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners